Knock-down of COX-2 expression or inhibition of COX-2 activity using a pharmacological inhibitor strikingly blocked TGF-β-induced tumorsphere formation, enrichment of CD24lowCD44high, ALDH+ breast cancer stem cells and breast cancer stem cell self-renewal [45]. This evidence concerns the gene PTGS2 and breast cancer.